1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neurosurgical Products Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neurosurgical Products Market, United States
3.1 Neurosurgical Products Market, United States, Revenue ($m), 2018-2033
3.1.1 Dura Substitutes Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Neuroendoscopes Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.3 Neurosurgical Drills Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Neurosurgical Products Market, United States, Volume (Units), 2018-2033
3.2.1 Dura Substitutes Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Neuroendoscopes Market, United States, Volume (Units), by Segment, 2018-2033
3.2.3 Neurosurgical Drills Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Neurosurgical Products Market, United States, Average Price ($), 2018-2033
3.4 Neurosurgical Products Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Neurosurgical Products Market, United States, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in United States, Neurosurgical Products Market
4.1 Integra LifeSciences Corp
4.1.1 Company Overview
4.2 Medtronic Plc
4.2.1 Company Overview
4.3 B. Braun Melsungen AG
4.3.1 Company Overview
4.4 Stryker Corp
4.4.1 Company Overview
4.5 KARL STORZ SE & Co KG
4.5.1 Company Overview
4.6 DePuy Synthes Inc
4.6.1 Company Overview
4.7 Clearmind Biomedical Inc
4.7.1 Company Overview
4.8 Baxter International Inc
4.8.1 Company Overview
4.9 Regenity Biosciences
4.9.1 Company Overview
5 Neurosurgical Products Market Pipeline Products6 Financial Deals Landscape
6.1 Debt Offerings
6.1.1 Stryker Raises USD883.83 Million Public Offering of 3.375% Notes Due 2032
6.1.2 Stryker Raises USD662.87 Million in Public Offering of 3.625% Notes Due 2036
7 Recent Developments
7.1 Corporate Communications
7.1.1 Feb 28, 2024: Bob Azelby to Join Cardinal Health Board of Directors
7.2 Financial Announcements
7.2.1 Jan 27, 2025: Organogenesis Holdings to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025
7.2.2 Dec 19, 2024: Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2025 on January 30
7.2.3 Nov 01, 2024: Cardinal Health Announces Q1 Fiscal Year 2025 Results
7.2.4 Oct 17, 2024: ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024
7.2.5 Oct 01, 2024: Stryker to Announce Its Third Quarter 2024 Financial Results
7.2.6 Aug 14, 2024: Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance
7.2.7 Jul 17, 2024: ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024
7.2.8 Jul 15, 2024: Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024
7.2.9 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 The Publisher's Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Dura Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Neuroendoscopes Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Neurosurgical Drills Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 5: Neurosurgical Products Market, United States, Volume (Units), 2018-2033
Table 6: Dura Substitutes Market, United States, Volume (Units), 2018-2033
Table 7: Neuroendoscopes Market, United States, Volume (Units), 2018-2033
Table 8: Neurosurgical Drills Market, United States, Volume (Units), 2018-2033
Table 9: Neurosurgical Products Market, United States, Average Price ($), 2018-2033
Table 10: Neurosurgical Products Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 11: Neurosurgical Products Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 12: Neurosurgical Products Market Pipeline Products
Table 13: Stryker Raises USD883.83 Million Public Offering of 3.375% Notes Due 2032
Table 14: Stryker Raises USD662.87 Million in Public Offering of 3.625% Notes Due 2036
Table 15: Total Number of Primary Research Participants, Neurology Devices Market, by Country
List of Figures
Figure 1: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Dura Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Neuroendoscopes Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Neurosurgical Drills Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 5: Neurosurgical Products Market, United States, Volume (Units), 2018-2033
Figure 6: Dura Substitutes Market, United States, Volume (Units), 2018-2033
Figure 7: Neuroendoscopes Market, United States, Volume (Units), 2018-2033
Figure 8: Neurosurgical Drills Market, United States, Volume (Units), 2018-2033
Figure 9: Neurosurgical Products Market, United States, Company Share (%) 2023